BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Breslow JM, Meissler JJ Jr, Hartzell RR, Spence PB, Truant A, Gaughan J, Eisenstein TK. Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance. Infect Immun 2011;79:3317-27. [PMID: 21576323 DOI: 10.1128/IAI.00069-11] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Barquero-Calvo E, Martirosyan A, Ordoñez-Rueda D, Arce-Gorvel V, Alfaro-Alarcón A, Lepidi H, Malissen B, Malissen M, Gorvel JP, Moreno E. Neutrophils exert a suppressive effect on Th1 responses to intracellular pathogen Brucella abortus. PLoS Pathog 2013;9:e1003167. [PMID: 23458832 DOI: 10.1371/journal.ppat.1003167] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
2 Qiu H, KuoLee R, Harris G, Van Rooijen N, Patel GB, Chen W. Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection. PLoS One 2012;7:e40019. [PMID: 22768201 DOI: 10.1371/journal.pone.0040019] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 6.1] [Reference Citation Analysis]
3 Campfield B, Chen K, Kolls JK. Vaccine approaches for multidrug resistant Gram negative infections. Curr Opin Immunol 2014;28:84-9. [PMID: 24637162 DOI: 10.1016/j.coi.2014.02.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
4 Weidensdorfer M, Ishikawa M, Hori K, Linke D, Djahanschiri B, Iruegas R, Ebersberger I, Riedel-Christ S, Enders G, Leukert L, Kraiczy P, Rothweiler F, Cinatl J, Berger J, Hipp K, Kempf VAJ, Göttig S. The Acinetobacter trimeric autotransporter adhesin Ata controls key virulence traits of Acinetobacter baumannii. Virulence 2019;10:68-81. [PMID: 31874074 DOI: 10.1080/21505594.2018.1558693] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
5 Liu D, Chen Z, Yuan Y, Jing H, Zou J, Zhang X, Zeng X, Zhang W, Zou Q, Zhang J. Innate Immune Effectors Play Essential Roles in Acute Respiratory Infection Caused by Klebsiella pneumoniae. J Immunol Res 2020;2020:5291714. [PMID: 33163539 DOI: 10.1155/2020/5291714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Garraud K, Cleret A, Mathieu J, Fiole D, Gauthier Y, Quesnel-Hellmann A, Tournier JN. Differential role of the interleukin-17 axis and neutrophils in resolution of inhalational anthrax. Infect Immun 2012;80:131-42. [PMID: 22025514 DOI: 10.1128/IAI.05988-11] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
7 Parra Millán R, Jiménez Mejías ME, Sánchez Encinales V, Ayerbe Algaba R, Gutiérrez Valencia A, Pachón Ibáñez ME, Díaz C, Pérez Del Palacio J, López Cortés LF, Pachón J, Smani Y. Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models. Antimicrob Agents Chemother 2016;60:4464-70. [PMID: 27161639 DOI: 10.1128/AAC.02708-15] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
8 de Breij A, Eveillard M, Dijkshoorn L, van den Broek PJ, Nibbering PH, Joly-Guillou ML. Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia. PLoS One 2012;7:e30673. [PMID: 22347396 DOI: 10.1371/journal.pone.0030673] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
9 Bhuiyan MS, Ellett F, Murray GL, Kostoulias X, Cerqueira GM, Schulze KE, Mahamad Maifiah MH, Li J, Creek DJ, Lieschke GJ, Peleg AY. Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis. Proc Natl Acad Sci U S A 2016;113:9599-604. [PMID: 27506797 DOI: 10.1073/pnas.1523116113] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 9.3] [Reference Citation Analysis]
10 Bentancor LV, Camacho-Peiro A, Bozkurt-Guzel C, Pier GB, Maira-Litrán T. Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii. J Bacteriol 2012;194:3950-60. [PMID: 22609912 DOI: 10.1128/JB.06769-11] [Cited by in Crossref: 65] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
11 Harris G, Holbein BE, Zhou H, Xu HH, Chen W. Potential Mechanisms of Mucin-Enhanced Acinetobacter baumannii Virulence in the Mouse Model of Intraperitoneal Infection. Infect Immun 2019;87:e00591-19. [PMID: 31405959 DOI: 10.1128/IAI.00591-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chen W. Current advances and challenges in the development of Acinetobacter vaccines. Hum Vaccin Immunother 2015;11:2495-500. [PMID: 26158773 DOI: 10.1080/21645515.2015.1052354] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
13 Lázaro-Díez M, Chapartegui-González I, Redondo-Salvo S, Leigh C, Merino D, Segundo DS, Fernández A, Navas J, Icardo JM, Acosta F, Ocampo-Sosa A, Martínez-Martínez L, Ramos-Vivas J. Human neutrophils phagocytose and kill Acinetobacter baumannii and A. pittii. Sci Rep 2017;7:4571. [PMID: 28676640 DOI: 10.1038/s41598-017-04870-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
14 Cypowyj S, Picard C, Maródi L, Casanova JL, Puel A. Immunity to infection in IL-17-deficient mice and humans. Eur J Immunol 2012;42:2246-54. [PMID: 22949323 DOI: 10.1002/eji.201242605] [Cited by in Crossref: 120] [Cited by in F6Publishing: 113] [Article Influence: 13.3] [Reference Citation Analysis]
15 Ketter PM, Guentzel MN, Schaffer B, Herzig M, Wu X, Montgomery RK, Parida BK, Fedyk CG, Yu JJ, Jorgensen J, Chambers JP, Cap AP, Arulanandam BP. Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3. Infect Immun 2014;82:3910-8. [PMID: 25001601 DOI: 10.1128/IAI.01958-14] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
16 Bergamini G, Perico ME, Di Palma S, Sabatini D, Andreetta F, Defazio R, Felici A, Ferrari L. Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: Comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques. PLoS One 2021;16:e0260627. [PMID: 34855837 DOI: 10.1371/journal.pone.0260627] [Reference Citation Analysis]
17 Kamuyu G, Suen Cheng Y, Willcocks S, Kewcharoenwong C, Kiratisin P, Taylor PW, Wren BW, Lertmemongkolchai G, Stabler RA, Brown J. Sequential Vaccination With Heterologous Acinetobacter baumannii Strains Induces Broadly Reactive Antibody Responses. Front Immunol 2021;12:705533. [PMID: 34394105 DOI: 10.3389/fimmu.2021.705533] [Reference Citation Analysis]
18 García-Patiño MG, García-Contreras R, Licona-Limón P. The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections. Front Immunol 2017;8:441. [PMID: 28446911 DOI: 10.3389/fimmu.2017.00441] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
19 Harris G, Kuo Lee R, Lam CK, Kanzaki G, Patel GB, Xu HH, Chen W. A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents Chemother 2013;57:3601-13. [PMID: 23689726 DOI: 10.1128/AAC.00944-13] [Cited by in Crossref: 76] [Cited by in F6Publishing: 49] [Article Influence: 8.4] [Reference Citation Analysis]
20 Naghipour Erami A, Rasooli I, Jahangiri A, Darvish Alipour Astaneh S. Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model. Microb Pathog 2021;161:105291. [PMID: 34798280 DOI: 10.1016/j.micpath.2021.105291] [Reference Citation Analysis]
21 Mora-Cartín R, Gutiérrez-Jiménez C, Alfaro-Alarcón A, Chaves-Olarte E, Chacón-Díaz C, Barquero-Calvo E, Moreno E. Neutrophils Dampen Adaptive Immunity in Brucellosis. Infect Immun 2019;87:e00118-19. [PMID: 30804100 DOI: 10.1128/IAI.00118-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
22 Coakley JD, Breen EP, Moreno-Olivera A, Al-Harbi AI, Melo AM, O'Connell B, McManus R, Doherty DG, Ryan T. Dysregulated T helper type 1 (Th1) and Th17 responses in elderly hospitalised patients with infection and sepsis. PLoS One 2019;14:e0224276. [PMID: 31658288 DOI: 10.1371/journal.pone.0224276] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Lee HH, Aslanyan L, Vidyasagar A, Brennan MB, Tauber MS, Carrillo-Sepulveda MA, Dores MR, Rigel NW, Martinez LR. Depletion of Alveolar Macrophages Increases Pulmonary Neutrophil Infiltration, Tissue Damage, and Sepsis in a Murine Model of Acinetobacter baumannii Pneumonia. Infect Immun 2020;88:e00128-20. [PMID: 32366576 DOI: 10.1128/IAI.00128-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 May HC, Yu JJ, Zhang H, Wang Y, Cap AP, Chambers JP, Guentzel MN, Arulanandam BP. Thioredoxin-A is a virulence factor and mediator of the type IV pilus system in Acinetobacter baumannii. PLoS One 2019;14:e0218505. [PMID: 31265467 DOI: 10.1371/journal.pone.0218505] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
25 Jun SH, Lee JH, Kim BR, Kim SI, Park TI, Lee JC, Lee YC. Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins. PLoS One 2013;8:e71751. [PMID: 23977136 DOI: 10.1371/journal.pone.0071751] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 7.1] [Reference Citation Analysis]
26 He XD, Wang Y, Wu Q, Wang HX, Chen ZD, Zheng RS, Wang ZS, Wang JB, Yang Y. Xuebijing Protects Rats from Sepsis Challenged with Acinetobacter baumannii by Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines Secretion. Evid Based Complement Alternat Med. 2013;2013:804940. [PMID: 24369483 DOI: 10.1155/2013/804940] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
27 Miró-Canturri A, Ayerbe-Algaba R, Jiménez-Mejías ME, Pachón J, Smani Y. Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models. Antibiotics (Basel) 2021;10:194. [PMID: 33671416 DOI: 10.3390/antibiotics10020194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Geisinger E, Isberg RR. Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii. PLoS Pathog 2015;11:e1004691. [PMID: 25679516 DOI: 10.1371/journal.ppat.1004691] [Cited by in Crossref: 243] [Cited by in F6Publishing: 129] [Article Influence: 34.7] [Reference Citation Analysis]
29 Lin L, Tan B, Pantapalangkoor P, Ho T, Hujer AM, Taracila MA, Bonomo RA, Spellberg B. Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes. Vaccine 2013;31:313-8. [PMID: 23153442 DOI: 10.1016/j.vaccine.2012.11.008] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
30 Yan Z, Yang J, Hu R, Hu X, Chen K. Acinetobacter baumannii Infection and IL-17 Mediated Immunity. Mediators Inflamm 2016;2016:9834020. [PMID: 26977122 DOI: 10.1155/2016/9834020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
31 Breslow JM, Monroy MA, Daly JM, Meissler JJ, Gaughan J, Adler MW, Eisenstein TK. Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection. J Neuroimmune Pharmacol 2011;6:551-65. [PMID: 21826405 DOI: 10.1007/s11481-011-9303-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
32 Pires S, Parker D. Innate Immune Responses to Acinetobacter baumannii in the Airway. J Interferon Cytokine Res 2019;39:441-9. [PMID: 31013462 DOI: 10.1089/jir.2019.0008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
33 Kale SD, Dikshit N, Kumar P, Balamuralidhar V, Khameneh HJ, Bin Abdul Malik N, Koh TH, Tan GGY, Tan TT, Mortellaro A, Sukumaran B. Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungs. Sci Rep 2017;7:17429. [PMID: 29234083 DOI: 10.1038/s41598-017-17653-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
34 Dikshit N, Kale SD, Khameneh HJ, Balamuralidhar V, Tang CY, Kumar P, Lim TP, Tan TT, Kwa AL, Mortellaro A, Sukumaran B. NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection. Mucosal Immunol 2018;11:257-72. [PMID: 28612844 DOI: 10.1038/mi.2017.50] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
35 Mendoza AE, Neely CJ, Charles AG, Kartchner LB, Brickey WJ, Khoury AL, Sempowski GD, Ting JP, Cairns BA, Maile R. Radiation combined with thermal injury induces immature myeloid cells. Shock 2012;38:532-42. [PMID: 23042190 DOI: 10.1097/SHK.0b013e31826c5b19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
36 Li X, Liu X, Horvatovich P, Hu Y, Zhang J. Proteomics Landscape of Host-Pathogen Interaction in Acinetobacter baumannii Infected Mouse Lung. Front Genet 2021;12:563516. [PMID: 34025711 DOI: 10.3389/fgene.2021.563516] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Yoon EJ, Balloy V, Fiette L, Chignard M, Courvalin P, Grillot-Courvalin C. Contribution of the Ade Resistance-Nodulation-Cell Division-Type Efflux Pumps to Fitness and Pathogenesis of Acinetobacter baumannii. mBio 2016;7:e00697-16. [PMID: 27247231 DOI: 10.1128/mBio.00697-16] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
38 Morris FC, Dexter C, Kostoulias X, Uddin MI, Peleg AY. The Mechanisms of Disease Caused by Acinetobacter baumannii. Front Microbiol 2019;10:1601. [PMID: 31379771 DOI: 10.3389/fmicb.2019.01601] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 19.3] [Reference Citation Analysis]
39 Kamoshida G, Kikuchi-Ueda T, Nishida S, Tansho-Nagakawa S, Ubagai T, Ono Y. Pathogenic Bacterium Acinetobacter baumannii Inhibits the Formation of Neutrophil Extracellular Traps by Suppressing Neutrophil Adhesion. Front Immunol 2018;9:178. [PMID: 29467765 DOI: 10.3389/fimmu.2018.00178] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
40 Harris G, KuoLee R, Xu HH, Chen W. Acute intraperitoneal infection with a hypervirulent Acinetobacter baumannii isolate in mice. Sci Rep 2019;9:6538. [PMID: 31024025 DOI: 10.1038/s41598-019-43000-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
41 Tiku V. Acinetobacter baumannii: Virulence Strategies and Host Defense Mechanisms. DNA Cell Biol 2021. [PMID: 34941456 DOI: 10.1089/dna.2021.0588] [Reference Citation Analysis]
42 Hood MI, Uzhachenko R, Boyd K, Skaar EP, Ivanova AV. Loss of mitochondrial protein Fus1 augments host resistance to Acinetobacter baumannii infection. Infect Immun 2013;81:4461-9. [PMID: 24042119 DOI: 10.1128/IAI.00771-13] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
43 Grguric-Smith LM, Lee HH, Gandhi JA, Brennan MB, DeLeon-Rodriguez CM, Coelho C, Han G, Martinez LR. Neutropenia exacerbates infection by Acinetobacter baumannii clinical isolates in a murine wound model. Front Microbiol 2015;6:1134. [PMID: 26528277 DOI: 10.3389/fmicb.2015.01134] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
44 Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. Clin Microbiol Rev 2017;30:409-47. [PMID: 27974412 DOI: 10.1128/CMR.00058-16] [Cited by in Crossref: 344] [Cited by in F6Publishing: 204] [Article Influence: 68.8] [Reference Citation Analysis]
45 Doi Y, Murray GL, Peleg AY. Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Semin Respir Crit Care Med 2015;36:85-98. [PMID: 25643273 DOI: 10.1055/s-0034-1398388] [Cited by in Crossref: 132] [Cited by in F6Publishing: 123] [Article Influence: 18.9] [Reference Citation Analysis]
46 Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol 2018;16:91-102. [PMID: 29249812 DOI: 10.1038/nrmicro.2017.148] [Cited by in Crossref: 253] [Cited by in F6Publishing: 231] [Article Influence: 50.6] [Reference Citation Analysis]
47 Tsuji BT, Landersdorfer CB, Lenhard JR, Cheah SE, Thamlikitkul V, Rao GG, Holden PN, Forrest A, Bulitta JB, Nation RL, Li J. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 2016;60:3913-20. [PMID: 27067330 DOI: 10.1128/AAC.02831-15] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
48 Allemailem KS, Almatroudi A, Alrumaihi F, Aljaghwani A, Alnuqaydan AM, Khalilullah H, Younus H, El-Kady AM, Aldakheel FM, Khan AA, Khan A, Khan MA. Antimicrobial, Immunomodulatory and Anti-Inflammatory Potential of Liposomal Thymoquinone: Implications in the Treatment of Bacterial Pneumonia in Immunocompromised Mice. Biomedicines 2021;9:1673. [PMID: 34829902 DOI: 10.3390/biomedicines9111673] [Reference Citation Analysis]
49 Chen Y, Guo J, Shi D, Fang D, Chen C, Li L. Ascitic Bacterial Composition Is Associated With Clinical Outcomes in Cirrhotic Patients With Culture-Negative and Non-neutrocytic Ascites. Front Cell Infect Microbiol 2018;8:420. [PMID: 30555804 DOI: 10.3389/fcimb.2018.00420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
50 Noto MJ, Boyd KL, Burns WJ, Varga MG, Peek RM Jr, Skaar EP. Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection. Infect Immun 2015;83:4134-41. [PMID: 26238713 DOI: 10.1128/IAI.00410-15] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
51 Chen W. Host Innate Immune Responses to Acinetobacter baumannii Infection. Front Cell Infect Microbiol 2020;10:486. [PMID: 33042864 DOI: 10.3389/fcimb.2020.00486] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
52 Zeng X, Gu H, Peng L, Yang Y, Wang N, Shi Y, Zou Q. Transcriptome Profiling of Lung Innate Immune Responses Potentially Associated With the Pathogenesis of Acinetobacter baumannii Acute Lethal Pneumonia. Front Immunol 2020;11:708. [PMID: 32391015 DOI: 10.3389/fimmu.2020.00708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
53 Mortensen BL, Skaar EP. Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection. Cell Microbiol 2012;14:1336-44. [PMID: 22640368 DOI: 10.1111/j.1462-5822.2012.01817.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 6.6] [Reference Citation Analysis]